Newsroom
Why We Can Have Both Innovative Drugs and Lower Drug Prices
Politico
10.15.2021
Medicare Is Sticking With Mandatory Demonstration Models for Now
MedPage Today
10.06.2021
The U.S. Can Lower Drug Prices Without Sacrificing Innovation
Harvard Business Review
10.04.2021
Letting the government negotiate drug prices won’t hurt innovation
The Washington Post
09.22.2021
Injuries Mount as Sales Reps for Device Makers Cozy Up to Surgeons, Even in Operating Rooms
Kaiser Health News
08.09.2021
Podcast: The Medicare Cliff
Tradeoffs
08.09.2021
Medicare Solvency Projections and Potential Policy Solutions
Alliance for Health Policy
08.09.2021
Addressing Medicare Solvency Will Require Both Revenue and Spending Changes
CommonwealthFund
08.09.2021
Keenan: More Affordable Care Act addresses lessons learned during the pandemic
The Patriot Ledger
07.19.2021
‘Modern-day redlining’: Execs, legislators say hospital reimbursement rates must be made equal
Boston Business Journal
07.19.2021
Oregon Legislature ends session with bills to address health care costs, expand mental health
Portland Business Journal
07.19.2021
States Are Leading the Way on a Public Health Insurance Option
Time Magazine
07.19.2021
Congressman Andy Kim and Local Health Advocates Highlight How High Drug Prices Hurt New Jersey Seniors and the Need for Rx Drug Reform
New Jersey Insider
07.19.2021
Group That Boosted Menendez Re-Election Now Spending To Lobby Him
New Jersey Globe
07.19.2021
Biden Asks HHS To Craft Drug Pricing Plan In 45 Days; Pushes Imports, Pay-For-Delay Ban
InsideHealthPolicy
07.19.2021
Pharma Now Faces Pricing Pressure From Both Biden Administration And Congress
InsideHealthPolicy
07.19.2021
ANALYSIS | Connecticut Needs to Focus on Real Health Reform
CT News Junkie
07.19.2021
EDITORIAL: Negotiate prices for drugs on Medicare Part D
Republican & Herald
07.19.2021
Massachusetts Patient Urges Legislators To Address High Drug Prices For Bay Staters
Patients for Affordable Drugs Now
07.19.2021
